<DOC>
	<DOCNO>NCT01695291</DOCNO>
	<brief_summary>This study examine feasibility potential efficacy augment SRIs minocycline . The study ass whether addition minocycline lead measurable change striatal glutamate ( Glu ) level . This study recruit 45 youth age 8-20 diagnose clinically significant OCD demonstrate minimal response SRI treatment currently stable dose SRI medication least 12 week . Participants randomize receive either 12 week minocycline treatment pill placebo . Randomization 2:1 2 3 participant receive minocycline . Screening eligibility take place 1-4 week . Participants undergo MRS scan measure striatal Glu level prior randomization , immediately follow treatment period . During treatment period , participant meet initially weekly every week study psychiatrist . All participant offer three month open medication treatment follow participation . The clinical trial conduct NYSPI MRS scan may conduct Weill Cornell Medical Center NYSPI .</brief_summary>
	<brief_title>Novel Medication Strategies Targeting Brain Mechanisms Pediatric OCD</brief_title>
	<detailed_description>Please see brief summary study description .</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Participants must age 820 time consent Participants must weigh least 25kg Participants parent/guardian must able read understand English Participants must meet diagnostic criterion obsessivecompulsive disorder score â‰¥ 16 Children 's YaleBrown Obsessive Compulsive Scale ( CYBOCS ) Participants must stable dose serotonin reuptake inhibitor ( SRI ) medication , must minimal adequate trial SRI medication Report least minimal , full , response current SRI medication warrant ongoing SRI treatment For participant young 18 , write informed assent participant consent parent . For participant 18 old , write consent participant permission legal guardian/parent provide information Lifetime diagnosis : psychotic disorder , bipolar disorder , eat disorder , pervasive developmental disorder , mental retardation , substance/alcohol dependence Current diagnosis major depressive disorder , Tourette's/Tic Disorder , substance/alcohol abuse Positive urine screen illicit drug Medical psychiatric condition would make participation study unsafe Active suicidal ideation Females use hormonal birth control Presence metallic device dental brace incompatible MRS IQ &lt; 80 OCD patient primary symptom hoard ( determine CYBOCS checklist ) Current past diagnosis pediatric autoimmune neuropsychiatric disorder associate streptococcus ( PANDAS ) Individuals currently receive Exposure Response Prevention therapy acute phase treatment . Documented history hypersensitivity intolerance tetracycline antibiotic Use medication contraindicate minocycline ( e.g. , concomitant use antacid , iron , calcium , magnesium , aluminum , zinc salt impair minocycline absorption ; anticoagulant drug minocycline show depress plasma prothrombin activity ; antibiotic Accutane due rare side effect pseudotumor cerebri ) Inability participant parent/guardian read understand English</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Obsessive compulsive disorder</keyword>
</DOC>